Cover Image
市場調查報告書

代謝系統檢驗的全球市場 (∼2019年):各產品 (CPET、身體組成分析、ECG、可攜式系統)、用途 (重症加護、文明病)、技術 (REE、身體組成分析)、終端用戶 (健身房、運動、醫院)

Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital): Global Forecast to 2019

出版商 MarketsandMarkets 商品編碼 326372
出版日期 內容資訊 英文 148 Pages
訂單完成後即時交付
價格
Back to Top
代謝系統檢驗的全球市場 (∼2019年):各產品 (CPET、身體組成分析、ECG、可攜式系統)、用途 (重症加護、文明病)、技術 (REE、身體組成分析)、終端用戶 (健身房、運動、醫院) Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital): Global Forecast to 2019
出版日期: 2015年03月19日 內容資訊: 英文 148 Pages
簡介

全球代謝系統檢驗市場預計從2014年到2019年以7.41%的年複合成長率發展,從2014年的3億3278萬美元,成長到2019年的4億7575萬美元規模。在預測期間內促進市場成長的主要原因是文明病的增加,還有預計技術的進步和醫療費的擴大也成為大要素。同時,預計設備和軟體的高成本性和償付上的課題成為妨礙市場成長的要素。

本報告提供全球代謝系統檢驗的市場調查、產業結構、市場的各種影響因素分析、各產品區分、技術區分、用途、終端用戶的市場規模的變化與預測、各地區的趨勢、競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 預測大幅度成長的代謝系統檢驗市場
  • 生命週期分析:各地區

第5章 市場概要

  • 簡介
  • 市場區隔
    • 各產品
    • 各用途
    • 各檢查
    • 各終端用戶
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會

第6章 產業分析

  • 簡介
  • 波特的五力分析
  • 策略性基準
  • 供應鏈分析

第7章 代謝系統檢驗市場:各產品

  • 簡介
  • CPET系統
  • 代謝檢測設備
  • ECG、EKG系統
  • 身體組成分析儀
  • 軟體

第8章 代謝系統檢驗市場:各用途

  • 簡介
  • 文明病
  • 重症加護
  • 人類表現測試
  • 代謝異常X症候群
  • 代謝異常
  • 其他

第9章 代謝系統檢驗市場:各技術

  • 簡介
  • 最大氧攝取數量分析
  • RMR分析
  • 身體組成分析

第10章 代謝系統檢驗市場:各終端用戶

  • 簡介
  • 醫院
  • 檢驗室
  • 運動訓練中心
  • 健身房
  • 其他

第11章 地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 其他

第12章 競爭環境

  • 概要
  • 主要企業
  • 競爭環境、趨勢

第13章 企業簡介

  • 簡介
  • Carefusion Corporation
  • General Electric Company
  • Geratherm Medical AG
  • MGC Diagnostics Corporation
  • OSI Systems, Inc.
  • AEI Technologies, Inc.
  • Cortex Biophysik GMBH
  • Cosmed
  • Korr Medical Technologies, Inc.
  • Microlife Medical Home Solutions, Inc.
  • Parvo Medics
    • 產業概要
    • 產品系列
    • 近幾年的發展趨勢
    • 主要策略等

第14章 附錄

圖表一覽

目錄
Product Code: MD 3251

In this report, the global metabolic testing market is segmented on the basis of products, technologies, applications, end users, and regions. The product segments of the market included in the report are CPET systems, metabolic carts, ECGs and EKGs, body composition analyzers, and software. The technology segments of the market included in the report are VO2 max analysis, RMR analysis, and body composition analysis. The application segments of the market included in the report are lifestyle diseases, critical care, human performance testing, dysmetabolic syndrome X, metabolic disorders, and other applications. The end-user segments of the market included in the report are hospitals, laboratories, sports training centers, gyms, and other end users. The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW).

Rising prevalence of lifestyle diseases are the primary drivers for this market. Market growth will also be aided by technological advancements and increasing healthcare expenditure.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global metabolic testing market and its subsegments. Secondary information was used to identify the overall revenue, geographic reach, and product portfolios of the market players. Estimates of the metabolic testing market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth. The report includes company profiles and a competitive landscape of the metabolic testing market. The company profiles include the financial performances, product portfolios, and developments of each company; whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analysis of industry developments such as acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development: Product portfolios of the top players in the metabolic testing market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the metabolic testing market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the metabolic testing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various metabolic testing equipment and software across geographies

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Markets Covered
    • 1.3.2. Years Considered for the Study
  • 1.4. Currency
  • 1.5. Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Breakdown and Data Triangulation
  • 2.3. Market Share Estimation
    • 2.3.1. Key Data From Secondary Sources
    • 2.3.2. Key Data From Primary Sources
    • 2.3.3. Assumptions for the Study

3. Executive Summary

4. Premium Insights

  • 4.1. Metabolic Testing Market to Experience Significant Growth
  • 4.2. Life Cycle Analysis, By Region

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Metabolic Testing Market, By Product
    • 5.2.2. Market, By Application
    • 5.2.3. Market, By Test
    • 5.2.4. Market, By End User
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Increasing Healthcare Expenditure
      • 5.3.1.2. Rising Incidence of Lifestyle Diseases
      • 5.3.1.3. Technological Advancements
    • 5.3.2. Restraints
      • 5.3.2.1. High Cost of Equipment and Software
      • 5.3.2.2. Reimbursement Issues
    • 5.3.3. Opportunities
      • 5.3.3.1. Emerging Economies

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Porter's Five Forces Analysis
    • 6.2.1. Threat From New Entrants
    • 6.2.2. Threat of Substitutes
    • 6.2.3. Bargaining Power of Buyers
    • 6.2.4. Bargaining Power of Suppliers
    • 6.2.5. Intensity of Rivalry
  • 6.3. Strategic Benchmarking
  • 6.4. Supply Chain Analysis
    • 6.4.1. Key Influencer

7. Metabolic Testing Market, By Product

  • 7.1. Introduction
  • 7.2. CPET Systems
  • 7.3. Metabolic Carts
  • 7.4. ECG and EKG Systems
  • 7.5. Body Composition Analyzers
  • 7.6. Software

8. Metabolic Testing Market, By Application

  • 8.1. Introduction
  • 8.2. Lifestyle Diseases
  • 8.3. Critical Care
  • 8.4. Human Performance Testing
  • 8.5. Dysmetabolic Syndrome X
  • 8.6. Metabolic Disorders
  • 8.7. Other Applications

9. Metabolic Testing Market, By Technology

  • 9.1. Introduction
  • 9.2. VO2. Max Analysis
  • 9.3. RMR Analysis
  • 9.4. Body Composition Analysis

10. Metabolic Testing Market, By End User

  • 10.1. Introduction
  • 10.2. Hospitals
  • 10.3. Laboratories
  • 10.4. Sports Training Centers
  • 10.5. GYMS
  • 10.6. Other End Users

11. Geographic Analysis

  • 11.1. Introduction
  • 11.2. North America
  • 11.3. Europe
  • 11.4. Asia
  • 11.5. Rest of the World

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Leading Players in the Metabolic Testing Market
  • 12.3. Competitive Situation and Trends
    • 12.3.1. New Product Launches
    • 12.3.2. Agreements and Partnerships
    • 12.3.3. Acquisitions
    • 12.3.4. Expansions
    • 12.3.5. Other Developments

13. Company Profiles

  • 13.1. Introduction
  • 13.2. Carefusion Corporation
    • 13.2.1. Business Overview
    • 13.2.2. Product Portfolio
    • 13.2.3. Recent Developments
    • 13.2.4. MNM View
      • 13.2.4.1. Financial Analysis
      • 13.2.4.2. Strategic Analysis
  • 13.3. General Electric Company
    • 13.3.1. Business Overview
    • 13.3.2. Product Portfolio
    • 13.3.3. Recent Developments
    • 13.3.4. MNM View
      • 13.3.4.1. Financial Analysis
  • 13.4. Geratherm Medical AG
    • 13.4.1. Business Overview
    • 13.4.2. Product Portfolio
    • 13.4.3. Recent Developments
    • 13.4.4. MNM View
      • 13.4.4.1. Financial Analysis
  • 13.5. MGC Diagnostics Corporation
    • 13.5.1. Business Overview
    • 13.5.2. Product Portfolio
    • 13.5.3. Recent Developments
    • 13.5.4. MNM View
      • 13.5.4.1. Financial Analysis
      • 13.5.4.2. Strategic Analysis
  • 13.6. OSI Systems, Inc.
    • 13.6.1. Business Overview
    • 13.6.2. Product Portfolio
    • 13.6.3. Recent Developments
    • 13.6.4. MNM View
      • 13.6.4.1. Financial Analysis
      • 13.6.4.2. Strategic Analysis
  • 13.7. AEI Technologies, Inc.
    • 13.7.1. Business Overview
    • 13.7.2. Product Portfolio
    • 13.7.3. Recent Developments
    • 13.7.4. Key Strategy
  • 13.8. Cortex Biophysik GMBH
    • 13.8.1. Business Overview
    • 13.8.2. Product Portfolio
    • 13.8.3. Recent Developments
    • 13.8.4. Key Strategy
  • 13.9. Cosmed
    • 13.9.1. Business Overview
    • 13.9.2. Product Portfolio
    • 13.9.3. Recent Developments
    • 13.9.4. Key Strategy
  • 13.1. Korr Medical Technologies, Inc.
    • 13.10.1. Business Overview
    • 13.10.2. Product Portfolio
    • 13.10.3. Recent Developments
    • 13.10.4. Key Strategy
  • 13.11. Microlife Medical Home Solutions, Inc.
    • 13.11.1. Business Overview
    • 13.11.2. Product Portfolio
    • 13.11.3. Recent Developments
    • 13.11.4. Key Strategy
  • 13.12. Parvo Medics
    • 13.12.1. Business Overview
    • 13.12.2. Product Portfolio
    • 13.12.3. Recent Developments
    • 13.12.4. Key Strategy

14. Appendix

  • 14.1. Insights of Industry Experts
  • 14.2. Discussion Guide
  • 14.3. Introducing RT: Real-Time Market Intelligence
  • 14.4. Available Customizations
  • 14.5. Related Reports

List of Tables

  • Table 1: Metabolic Testing Market Summary
  • Table 2: Market Developments Between 2010 and 2014
  • Table 3: Global Metabolic Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 4: Market Size for CPET Systems, By Region, 2012-2019 ($Million)
  • Table 5: Market Size for CPET Systems, By Type, 2012-2019 ($Million)
  • Table 6: Metabolic Carts Market Size, By Region, 2012-2019 ($Million)
  • Table 7: Metabolic Carts Market Size, By Type, 2012-2019 ($Million)
  • Table 8: Market Size for ECG and EKG Systems, By Region, 2012-2019 ($Million)
  • Table 9: Market Size for ECG and EKG Systems, By Type, 2012-2019 ($Million)
  • Table 10: Market Size for Body Composition Analyzers, By Region, 2012-2019 ($Million)
  • Table 11: Market Size for Body Composition Analyzers, By Type, 2012-2019 ($Million)
  • Table 12: Market Size for Software, By Region, 2012-2019 ($Million)
  • Table 13: Market Size, By Application, 2012-2019 ($Million)
  • Table 14: Market Size for Lifestyle Diseases, By Region, 2012-2019 ($Million)
  • Table 15: Market Size for Critical Care, By Region, 2012-2019 ($Million)
  • Table 16: Market Size for Human Performance Testing, By Region, 2012-2019 ($Million)
  • Table 17: Market Size for Dysmetabolic Syndrome X , By Region, 2012-2019 ($Million)
  • Table 18: Market Size for Metabolic Disorders, By Region, 2012-2019 ($Million)
  • Table 19: Market Size for Other Applications, By Region, 2012-2019 ($Million)
  • Table 20: Market Size, By Technology, 2012-2019 ($Million)
  • Table 21: VO2 Max Analysis Market Size, By Region, 2012-2019 ($Million)
  • Table 22: RMR Analysis Market Size, By Region, 2012-2019 ($Million)
  • Table 23: Body Composition Analysis Market Size, By Region, 2012-2019 ($Million)
  • Table 24: Market Size, By End User, 2012-2019 ($Million)
  • Table 25: Market Size for Hospitals, By Region, 2012-2019 ($Million)
  • Table 26: Market Size for Laboratories, By Region, 2012-2019 ($Million)
  • Table 27: Market Size for Sports Training Centers, By Region, 2012-2019 ($Million)
  • Table 28: Market Size for GYMS, By Region, 2012-2019 ($Million)
  • Table 29: Market Size for Other End Users, By Region, 2012-2019 ($Million)
  • Table 30: Market, By Region, 2012-2019 ($Million)
  • Table 31: North America: Market Size, By Product, 2012-2019 ($Million)
  • Table 32: North America: CPET Systems Market, By Type, 2012-2019 ($Million)
  • Table 33: North America: Metabolic Carts Market, By Type, 2012-2019 ($Million)
  • Table 34: North America: ECG and EKG Systems Market, By Type, 2012-2019 ($Million)
  • Table 35: North America: Body Composition Analyzers Market, By Type, 2012-2019 ($Million)
  • Table 36: North America: Market, By Application, 2012-2019 ($Million)
  • Table 37: North America: Market, By Technology, 2012-2019 ($Million)
  • Table 38: North America: Market, By End User, 2012-2019 ($Million)
  • Table 39: Europe: Market, By Products, 2012-2019 ($Million)
  • Table 40: Europe: CPET Systems Market, By Type, 2012-2019 ($Million))
  • Table 41: Europe: Metabolic Carts Market, By Type, 2012-2019 ($Million)
  • Table 42: Europe: ECG and EKG Systems Market, By Type, 2012-2019 ($Million)
  • Table 43: Europe: Body Composition Analyzers Market, By Type, 2012-2019 ($Million)
  • Table 44: Europe: Market, By Application, 2012-2019 ($Million)
  • Table 45: Europe: Market, By Technology, 2012-2019 ($Million)
  • Table 46: Europe: Market, By End User, 2012-2019 ($Million)
  • Table 47: Asia: Market, By Product, 2012-2019 ($Million)
  • Table 48: Asia: CPET Systems Market, By Type, 2012-2019 ($Million))
  • Table 49: Asia: Metabolic Carts Market, By Type, 2012-2019 ($Million)
  • Table 50: Asia: ECG and EKG Systems Market, By Type, 2012-2019 ($Million)
  • Table 51: Asia: Body Composition Analyzers Market, By Type, 2012-2019 ($Million)
  • Table 52: Asia: Metabolic Testing Market, By Application, 2012-2019 ($Million)
  • Table 53: Asia: Metabolic Testing Market, By Technology, 2012-2019 ($Million)
  • Table 54: Asia: Metabolic Testing Market, By End User, 2012-2019 ($Million)
  • Table 55: ROW: Market, By Product, 2012-2019 ($Million)
  • Table 56: ROW: CPET Systems Market, By Type, 2012-2019 ($Million)
  • Table 57: ROW: Metabolic Carts Market, By Type, 2012-2019 ($Million)
  • Table 58: ROW: ECG and EKG Systems Market, By Type, 2012-2019 ($Million)
  • Table 59: ROW: Body Composition Analyzers Market, By Type, 2012-2019 ($Million)
  • Table 60: ROW: Metabolic Testing Market, By Application, 2012-2019 ($Million)
  • Table 61: ROW: Metabolic Testing Market, By Technology, 2012-2019 ($Million)
  • Table 62: ROW: Metabolic Testing Market, By End User, 2012-2019 ($Million)
  • Table 63: Rank of Companies in the Global Metabolic Testing Market
  • Table 64: New Product Launches, 2011-2014
  • Table 65: Agreements and Partnerships, 2011-2014
  • Table 66: Acquisitions, 2011-2014
  • Table 67: Expansions, 2011-2014
  • Table 68: Other Developments, 2011-2014

List of Figures

  • Figure 1: Metabolic Testing Market
  • Figure 2: Research Methodology
  • Figure 3: Market Size Estimation Methodology: Bottom-Up Approach
  • Figure 4: Market Size Estimation Methodology: Top-Down Approach
  • Figure 5: Break Down of Primary Interviews: By Company Type, Designation, and Region
  • Figure 6: Data Triangulation Methodology
  • Figure 7: CPET Systems Was the Largest Product Segment of the Metabolic Testing Market in 2014
  • Figure 8: Lifestyle Diseases Was the Largest and Fastest-Growing Application Segment of the Metabolic Testing Market
  • Figure 9: VO2 Max Analysis Was the Largest and Fastest-Growing Test Segment of the Metabolic Testing Market
  • Figure 10: Hospitals Are the Largest and Fastest-Growing End User Segment of the Metabolic Testing Market
  • Figure 11: North America Was the Largest Regional Segment of the Metabolic Testing Market in 2014
  • Figure 12: The Market Will Grow Over 40% in the Forecast Period
  • Figure 13: VO2 Max Analysis to Dominate the Metabolic Testing Market
  • Figure 14: Asia to Grow at the Highest Rate During the Forecast Period
  • Figure 15: Asian Offers Lucrative Growth Opportunities
  • Figure 16: Metabolic Testing Market, By Product
  • Figure 17: Market, By Application
  • Figure 18: Market, By Test
  • Figure 19: Market, By End User
  • Figure 20: Market Dynamics
  • Figure 21: Increasing Healthcare Expenditure is the Most Important Growth Driver for the Metabolic Testing Market
  • Figure 22: Growth in Healthcare Expenditure in Asia and ROW Outpacing That in Europe and North America
  • Figure 23: High Capital Investments and Stringent Regulatory Policies to Restrict Entry of New Players
  • Figure 24: Direct Distribution, the Preferred Strategy By Prominent Companies
  • Figure 25: Market Segmentation, By Product
  • Figure 26: Market Size, By Product, 2014 ($Million)
  • Figure 27: North America Dominated CPET Systems Segment in 2014
  • Figure 28: North America Will Be the Fastest-Growing Regional Market for Metabolic Carts By 2019
  • Figure 29: North America Commanded Largest Share of ECG and EKG Systems Market in 2014
  • Figure 30: North America Commands Largest Share of Body Composition Analyzer System Market in 2014
  • Figure 31: North America Commands Largest Share of Software Market in 2014
  • Figure 32: Market Segmentation, By Application
  • Figure 33: Market, By Application, 2014 vs. 2019 ($Million)
  • Figure 34: North America to Command the Largest Share of Lifestyle Diseases Applications in 2019
  • Figure 35: Increasing Incidence of Lifestyle Diseases is Expected to Drive the Critical Care Application Segment in North America
  • Figure 36: North America Was the Fastest-Growing Market for Human Performance Testing in 2014
  • Figure 37: North America Was the Fastest-Growing Market for Dysmetabolic Syndrome X, in 2014
  • Figure 38: North America to Dominate the Metabolic Disorders Market in 2019
  • Figure 39: North America Commanded Largest Share of the Other Applications Market in 2014
  • Figure 40: Market, By Technology
  • Figure 41: Market, By Technology, 2011-2019 ($Million)
  • Figure 42: North America to Command the Largest Share of the VO2 Max Analysis Segment in 2019
  • Figure 43: North America to Dominate the RMR Analysis Segment in 2019
  • Figure 44: North America Was the Biggest Market for Body Composition Analysis in 2014
  • Figure 45: Market, By End User
  • Figure 46: Market, By End User, 2014 vs. 2019 ($Million)
  • Figure 47: North America to Command the Largest Share of the Hospitals End-User Segment in 2019
  • Figure 48: North America to Dominate the Laboratories End-User Segment in 2019
  • Figure 49: North America Was the Fastest-Growing Region for Sports Training Centers in 2014
  • Figure 50: North America Was the Fastest-Growing Region for the GYMS Segment in 2014
  • Figure 51: North America to Dominate the Metabolic Testing Market for Other End Users in 2019
  • Figure 52: Asia Expected to Grow at the Highest Rate From 2014 to 2019
  • Figure 53: Global Market Indicators
  • Figure 54: Metabolic Testing Market, By Region, 2014-2019 ($Million)
  • Figure 55: North America: Market Indicators
  • Figure 56: North America: Market Snapshot
  • Figure 57: North America: Metabolic Testing Market, By Product, 2012-2019 ($Million)
  • Figure 58: North America: Market, By Application, 2012-2019 ($Million)
  • Figure 59: North America: Market, By Technology, 2014 ($Million)
  • Figure 60: North America: Market, By End User, 2012-2019 ($Million)
  • Figure 61: Europe: Market Indicators
  • Figure 62: Europe: Metabolic Testing Market, By Product, 2014 ($Million)
  • Figure 63: Europe: Metabolic Market, By Application, 2014-2019 ($Million)
  • Figure 64: Europe: Metabolic Market, By Technology, 2014 ($Million)
  • Figure 65: Europe: Metabolic Market, By End Users, 2014-2019 ($Million)
  • Figure 66: Asia: Market Indicators
  • Figure 67: Asia: Market Snapshot
  • Figure 68: Asia: Metabolic Testing Market, By Product, 2014 ($Million)
  • Figure 69: Asia: Market, By Application, 2014-2019 ($Million)
  • Figure 70: Asia: Market, By Technology, 2014 ($Million)
  • Figure 71: Asia: Market, By End User, 2014-2019 ($Million)
  • Figure 72: ROW: Market Indicators
  • Figure 73: ROW: Metabolic Testing Market, By Product, 2014 ($Million)
  • Figure 74: ROW: Market, By Application, 2014-2019 ($Million)
  • Figure 75: ROW: Market, By Technology, 2014 ($Million)
  • Figure 76: ROW: Market, By End User, 2014-2019 ($Million)
  • Figure 77: New Product Launches Are the Key Strategy Adopted By Players
  • Figure 78: Battle for Market Share: New Product Launches Was the Key Strategy
  • Figure 79: Agreements and Partnerships, 2011-2014
  • Figure 80: Acquisitions, 2011-2014
  • Figure 81: Expansions, 2011-2014
  • Figure 82: Other Developments, 2011-2014
  • Figure 83: Geographic Revenue Mix of the Top 5 Market Players
  • Figure 84: Company Snapshot: Carefusion Corporation
  • Figure 85: Company Snapshot: General Electric Company
  • Figure 86: Company Snapshot: Geratherm Medical AG
  • Figure 87: Company Snapshot: MGC Diagnostics Corporation
  • Figure 88: Company Snapshot: OSI Systems, Inc.
Back to Top